Guardian Pharmacy Services, Inc.
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.4B
- Net income
- $49.2M
- Total assets
- $412.7M
- Market cap
- $2.6B
- Gross margin
- 20.2%
- Operating margin
- 5.0%
- Net margin
- 3.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.4B
- Cost of revenue
- $1.2B
- Gross profit
- $292.7M
- Operating expenses
- $220.0M
- Operating income
- $72.7M
- Income tax
- $24.5M
- Net income
- $49.0M
Balance sheet
- Total assets
- $412.7M
- Current assets
- $221.6M
- Total liabilities
- $194.7M
- Current liabilities
- $160.7M
- Shareholders’ equity
- $217.9M
Cash flow
- Operating cash flow
- $100.3M
- Investing cash flow
- -$32.2M
- Financing cash flow
- -$7.1M
- Net cash flow
- $61.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $2.6B
- Shares outstanding
- 63.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 26, 2024
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $49.2M in FY2025.
- Revenue grew 18% from FY2024 to FY2025.
- Gross margin of 20.2%, net margin 3.4%.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Guardian Pharmacy Services, Inc..
Write a review
News about Guardian Pharmacy Services, Inc.
News & sentiment via Polygon.io
